tiprankstipranks
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX

Protagenic Therapeutics (PTIX) Financial Statements

24 Followers

Protagenic Therapeutics Financial Overview

Protagenic Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.373; its P/E ratio is -0.56; Protagenic Therapeutics is scheduled to report earnings on April 1, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 1.75M$ -1.66M$ -1.36M$ -1.18M$ -739.29K
EBITDA$ 1.76M$ -1.63M$ -1.34M$ -1.15M$ -714.30K
Net Income Common Stockholders$ -1.72M$ -1.68M$ -1.40M$ -1.21M$ 808.17K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.42M$ 4.06M$ 5.27M$ 6.04M$ 7.65M
Total Assets$ 2.58M$ 4.32M$ 5.43M$ 6.92M$ 7.67M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.42M$ -4.06M$ -5.27M$ -6.04M$ -7.65M
Total Liabilities$ 446.10K$ 655.25K$ 1.28M$ 1.51M$ 1.25M
Stockholders Equity$ 2.13M$ 3.67M$ 4.15M$ 5.41M$ 6.41M
Cash Flow-
Free Cash Flow$ -1.66M$ -1.24M$ -711.57K$ -1.53M$ -371.83K
Operating Cash Flow$ -1.66M$ -1.14M$ -655.77K$ -1.53M$ -371.83K
Investing Cash Flow$ 1.20M$ 2.28M$ 590.72K$ 1.61M$ 294.67K
Financing Cash Flow-----
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

Protagenic Therapeutics Debt to Assets

Protagenic Therapeutics Cash Flow

Protagenic Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis